ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Malignancy"

  • 2018 American Transplant Congress

    Sirolimus Use Improves Cancer-Free Survival Following Transplantation: A Single Center 10-Year Analysis

    P. Chen,2 L. Nair,2 A. Ata,2 D. Conti,1 R. Lopez-Soler.1

    1Surgery, Section of Transplantation, Albany Medical College, Albany, NY; 2Surgery, Albany Medical College, Albany, NY.

    Introduction:In previous published results, we showed that the use of Sirolimus-based immunosuppression regimens had equivalent patient and graft 10-year survival compared to historical controls maintained…
  • 2018 American Transplant Congress

    Genomic Diversity of Epstein Barr Virus in Post-Transplant Lymphoproliferative Disorder

    E. Maloney,1 V. Busque,2 S. Hui,2 S. Krams,1,2 C. Esquivel,1,2 O. Martinez.1,2

    1Stanford Immunology, Stanford University School of Medicine, Stanford, CA; 2Department of Surgery/Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA.

    Purpose: In transplant recipients, Epstein-Barr Virus (EBV) is associated with the development of B cell lymphomas in post-transplant lymphoproliferative disorder (PTLD). We utilized next-generation sequencing…
  • 2018 American Transplant Congress

    A Novel Protocol to Improve Kidney Transplant Outcomes in Patients with Renal Disease Due to Amyloidosis

    A. Langone, B. Concepcion, D. Slosky, R. Cornell, S. Horst, S. Goodman.

    Vanderbilt University Medical Center, Nashville, TN.

    In 2011, members from 10 different medical disciplines formed the Vanderbilt Amyloid Multidisciplinary Program (VAMP) in an effort to improve regional recognition of this rare…
  • 2018 American Transplant Congress

    A Novel Nomogram-Based Approach for Defining the Effect of Transplantation on Cancer Recurrence Risk

    N. Ejaz,1 R. Alloway,1 F. Paterno,1 A. Singhal,1 X. Ji,2 M. Kattan,2 E. Woodle.1

    1U of Cincinnati, Cincinnati; 2Cleveland Clinic, Cleveland.

    The effect of transplantation on renal cell cancer (RCC) recurrence risk has not yet been precisely defined. Validated nomograms for predicting RCC recurrence risk (viz,…
  • 2018 American Transplant Congress

    Transplantation of Restored Kidneys from Living Related Donors after Small Renal Tumor Resection: Report of 5 Cases

    Y. Ogawa,1 S. Shiroma,2 K. Kojima,2 R. Mannami,2 M. Mannami,2 N. Mitsuhata,2 M. Nishi,4 H. Afuso.3

    1Urology, Tokyo-West Tokushukai Hospital, Akishima, Tokyo, Japan; 2Urology, Uwajima Toikushukai Hospital, Uwajima, Ehime, Japan; 3Urology, Okinawa Chubu Tokushukai Hospital, Okinawa, Japan; 4Urology, Saint Martin's Hospital, Sakaide, Kagawa, Japan.

    Purpose: We launched a clinical trial registered at ClinicalTrials.gov that aimed to study the utility and safety of restored kidney transplantation between family members using…
  • 2018 American Transplant Congress

    Organ Transplantation Associated with High Incidence of Anal Cancer and Pre-Cancer Lesions among HIV-Infected Women and Men

    P. Chin-Hong,1 B. Barin,2 M. Berry,1 M. DaCosta,1 T. Darragh,1 L. Rosenthal,3 S. Bartlett,4 D. Dieterich,5 F. Poordad,6 N. Nissen,6 M. Wong,7 P. Stock,1 J. Palefsky.1

    1University of California, San Francisco, San Francisco; 2EMMES, Rockville; 3Columbia University, New York; 4University of Maryland, Baltimore; 5Icahn School of Medicine at Mount Sinai, New York; 6Cedars-Sinai Medical Center, Los Angeles; 7Beth Israel Deaconess Medical Center, Boston.

    Objective: HIV-infected women and men and transplant recipients are two populations at increased risk of HPV-associated anal cancer but there is little published data. We…
  • 2018 American Transplant Congress

    Liver Transplantation as a Life Saving Procedure after Post Resection Liver Failure and Iatrogenic Liver Injuries

    T. Thorsen,1 J. Solheim,1 R. Horneland,1 P-.D. Line,1 K. Labori,2 E. Aandahl.1

    1Section for Transplant Surgery, Oslo University Hospital, Oslo, Norway; 2Section for Hepatobiliary Surgery, Oslo University Hospital, Oslo, Norway.

    Introduction: Iatrogenic injuries to vital structures of the liver and liver failure post liver resection are both associated with high mortality. Selected patients that were…
  • 2018 American Transplant Congress

    A Novel Dropout Risk Score in Hepatocellular Carcinoma (HCC) Patients Listed for Liver Transplant (LT) – Identifying a Threshold That Predicts Worse Post-LT Survival in Short Wait Regions

    N. Mehta, J. Dodge, F. Yao.

    UCSF, San Francisco.

    Background: Short wait time to LT for HCC patients may result in transplanting aggressive tumors at high risk for HCC recurrence who otherwise would have…
  • 2018 American Transplant Congress

    Malignancies in Kidney Transplant Recipients: A Long-Term Observational Study

    D. Khadzhynov, F. Halleck, F. Froehlich, L. Lehner, E. Schrezenmeyer, K. Budde, O. Staeck.

    Nephrology and Internal Intensive Care, Charite Universitaetsmedizin Berlin, Berlin, Germany.

    Background: Previous studies have shown increased incidence of malignancies in patients after kidney transplantation. However, most of the existing data on post-transplant malignancies is limited…
  • 2017 American Transplant Congress

    HCC and Cardiac Cirrhosis After the Fontan Procedure in a Patient with Congenital Heart Disease and Situs Inversus.

    P. Nguyen, N. Galvan, M. Kueht, C. O'Mahony, R. Cotton, A. Rana, J. Goss.

    Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX

    Introduction. Hypoplastic left heart syndrome (HLHS) is a fatal congenital cardiac anomaly for which surgical palliation is needed, the Fontan procedure. HLHS accounts for <5%…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences